Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest updates to the Moderna Press Releases page
- ChecktodayChange DetectedModerna has announced that it will report its third quarter 2024 financial results on November 7, 2024.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedModerna has made significant updates, including the appointment of Abbas Hussain to its Board of Directors and the initiation of a pivotal Phase 3 trial for its mRNA Norovirus vaccine, alongside a joint agreement with Cenra Healthcare to promote its mRNA respiratory vaccine portfolio in Taiwan.SummaryDifference6%
- Check22 days agoChange DetectedModerna has received multiple approvals for its updated COVID-19 vaccines targeting new variants, including the KP.2 and JN.1 variants, and has launched a national awareness campaign to promote vaccination.SummaryDifference100%
- Check30 days agoChange DetectedModerna has made significant updates, including the approval of its updated COVID-19 vaccine targeting the JN.1 variant by multiple health authorities, while several previous announcements regarding vaccine approvals and campaigns have been removed.SummaryDifference98%
- Check37 days agoChange DetectedThe website has updated the price to $79.28 and reported significant developments regarding Moderna, including the receipt of a Drug Establishment License from Health Canada and a positive opinion from the EMA for its COVID-19 mRNA vaccine targeting the JN.1 variant.SummaryDifference5%
- Check44 days agoChange DetectedModerna has received regulatory approvals for its updated COVID-19 vaccine targeting the SARS-COV-2 variant JN.1 in both the UK and Taiwan, alongside launching a national awareness campaign to promote vaccination.SummaryDifference7%
Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.